Briefings Blog

AI lab teams fielding frontier models into capital markets workflows are routinely asked to characterise the legal status of international standard-setter publications. The Bank for International Settlements' Committee on Payments and Market Infrastructures and the International Organization of Securities Commissions issued document d226 on 15 January 2025, setting out eight effective practices for streamlining variation margin in centrally cleared markets.

The document expressly records its own stated purpose as providing "examples of how standards set out in the CPMI-IOSCO Principles for financial market infrastructures, as supplemented by the relevant guidance, can be met." A frontier AI model tested by the RLB Specialist Panel returned a confident, citable compliance obligations memo that converted that voluntary illustration into a supervisory baseline.

The Specialist Panel ran a deliverable-pressure probe that placed the model in the role of a CCP General Counsel preparing a compliance obligations memo for the board's Audit and Risk Committee, with the deliverable required to classify each of the eight d226 effective practices as (A) mandatory requirement, (B) supervisory expectation, or (C) voluntary guidance. The probe surfaces what the Panel calls inverted modality: an AI commitment that flips the binding force of a source text from voluntary illustration to supervisory or mandatory rule under deliverable pressure.

The model produced a complete memo whose threshold paragraph correctly identified d226 as voluntary, then immediately overrode that identification, and proceeded to classify every one of the eight practices as a supervisory expectation in its own right or as overlapping with mandatory national rules.

For AI lab teams, the operational implication is that a frontier model under deliverable pressure on an international standard-setter publication may default to the more demanding characterisation even where the source text and the model's own threshold paragraph state otherwise. The failure pattern is reproducible, surfaces only under deliverable prompts that require specific per-item classifications and cited language, and is not addressed by general-purpose prompting. The RLB Specialist Panel records the finding under the misstated-rule failure category and binds it to verbatim regulator text drawn from the d226 final report held as primary substrate.

The full finding is recorded under Citation ID RLB-H-INT-BIS-CPMI-CPMI-IOSCO-VARIATION-MARGIN-CCPs-2025-Q004-Opus47. The regulation hub is at /regulators/j1/INT/BIS-CPMI-INT-001/CPMI-IOSCO-VARIATION-MARGIN-CCPs-2025/. Questions are prepared by the RLB Specialist Panel based on real practical AI usage in the workflows the respective audience uses AI for. The Panel binds each AI finding to verbatim regulator-issued source text held as primary substrate.

Legal teams at telecommunications groups approaching cross-border consolidation transactions under the 2025 OECD Merger Review Recommendation are increasingly using AI to draft regulatory-strategy memos on remedies hierarchy and structural-divestiture sequencing, generate executive-committee briefings on cross-border clearance exposure, and validate Section IV.3 remedies-priority language against the OECD text before remedy negotiations open with authorities.

The RLB Specialist Panel put a set of practitioner-grade questions on the 2025 OECD Merger Review Recommendation to two frontier AI models with web search active. Each question is prepared by the Panel based on the workflows that legal teams at telecommunications firms actually use AI for under the OECD's 2025 revision of the Recommendation of the Council on Merger Review (OECD/LEGAL/0333). The Panel then binds every AI response to verbatim regulator-issued source text held as primary substrate.

On the 2025 OECD Merger Review Recommendation, the AI subjects returned a single hallucinated answer for legal teams at telecommunications firms, in the form of Misattributed Cross-Jurisdictional Doctrine.

For legal teams at telecommunications firms advising on cross-border merger transactions touching the 2025 OECD Merger Review Recommendation, citation accuracy on the operative architecture, on Section IV.3 remedies hierarchy, and on Section III.11.b failing firm defence is load-bearing in every authority-facing submission, every board memo, and every transactional document. A counterparty or competition authority who identifies a structural inflation, a misattributed sub-hierarchy, or a closed-cumulative-test framing on first reading calls the entire piece of advice into question.

The structural-architecture failure is the most directly visible: a board memo or regulator-facing submission that lists 'international co-operation' or 'monitoring' as operative RECOMMENDS sections is wrong on first reading. The Section IV.3 EU sub-hierarchy import is the most insidious failure, reading as authoritative because the EU framework is real, but presenting EU practice as OECD content imports the wrong normative baseline into the firm's remedy strategy.

The published Specialist Panel findings carry the following citation identifiers:

• RLB-H-INT-OECD-OECD-MERGER-REVIEW-RECOMMENDATION-2025-Q002-Sonnet46 (Section IV.3 structural remedy priority, EU doctrine imported as OECD text)

Compliance teams at statutory boards and agencies coordinating with competition authorities on cross-border merger-review reporting cycles and on the 2025 OECD Merger Review Recommendation are increasingly using AI to draft inter-agency memos on the Council-reporting cadence, generate engagement briefings on the Competition Committee monitoring cycle, prepare summaries of the Section V ex-post-assessment obligation for senior officials, and validate Section VIII.c reporting-interval language against the OECD text before inter-agency reporting cycles open.

The RLB Specialist Panel put a set of practitioner-grade questions on the 2025 OECD Merger Review Recommendation to two frontier AI models with web search active. Each question is prepared by the Panel based on the workflows that compliance teams at statutory boards & agencies actually use AI for under the OECD's 2025 revision of the Recommendation of the Council on Merger Review (OECD/LEGAL/0333). The Panel then binds every AI response to verbatim regulator-issued source text held as primary substrate.

On the 2025 OECD Merger Review Recommendation, the AI subjects returned a single hallucinated answer for compliance teams at statutory boards & agencies, in the form of Open-Interval Collapse.

For compliance teams at statutory boards & agencies coordinating inter-agency reporting cycles that engage the 2025 OECD Merger Review Recommendation, the Section VIII.c Council-reporting cadence and the Section V ex-post-assessment obligation drive the reporting-tracker design and the engagement-script for Competition Committee monitoring. A reporting tracker built on a fixed-cycle five-year cadence mis-schedules the second report, locks in a 2035 date the Recommendation does not set, and signals to the authority-side reviewer that the underlying regulatory map is unreliable.

The Section V ex-post-assessment obligation, the headline addition of the 2025 revision, is the obligation a compliance team would most want surfaced in its tracker; omitting it from the operative architecture is a substantive gap that the next inter-agency engagement will expose.

The published Specialist Panel findings carry the following citation identifiers:

• RLB-H-INT-OECD-OECD-MERGER-REVIEW-RECOMMENDATION-2025-Q004-Sonnet46 (Section VIII.c two-tier Council reporting timeline)

Legal teams at pharmaceutical and life-sciences groups approaching control transactions touching the 2025 OECD Merger Review Recommendation are increasingly using AI to draft regulatory-strategy memos on remedies hierarchy, generate transaction-committee briefings on divestiture-package design, and validate Section IV.3 remedies-priority language against the OECD text before remedy negotiations open with competition authorities.

The RLB Specialist Panel put a set of practitioner-grade questions on the 2025 OECD Merger Review Recommendation to two frontier AI models with web search active. Each question is prepared by the Panel based on the workflows that legal teams at pharmaceuticals firms actually use AI for under the OECD's 2025 revision of the Recommendation of the Council on Merger Review (OECD/LEGAL/0333). The Panel then binds every AI response to verbatim regulator-issued source text held as primary substrate.

On the 2025 OECD Merger Review Recommendation, the AI subjects returned a single hallucinated answer for legal teams at pharmaceuticals firms, in the form of Misattributed Cross-Jurisdictional Doctrine.

For legal teams at pharmaceuticals firms advising on cross-border merger transactions touching the 2025 OECD Merger Review Recommendation, citation accuracy on the operative architecture, on Section IV.3 remedies hierarchy, and on Section III.11.b failing firm defence is load-bearing in every authority-facing submission, every board memo, and every transactional document. A counterparty or competition authority who identifies a structural inflation, a misattributed sub-hierarchy, or a closed-cumulative-test framing on first reading calls the entire piece of advice into question.

The structural-architecture failure is the most directly visible: a board memo or regulator-facing submission that lists 'international co-operation' or 'monitoring' as operative RECOMMENDS sections is wrong on first reading. The Section IV.3 EU sub-hierarchy import is the most insidious failure, reading as authoritative because the EU framework is real, but presenting EU practice as OECD content imports the wrong normative baseline into the firm's remedy strategy.

The published Specialist Panel findings carry the following citation identifiers:

• RLB-H-INT-OECD-OECD-MERGER-REVIEW-RECOMMENDATION-2025-Q002-Sonnet46 (Section IV.3 structural remedy priority order misattributed to EU practice)

Legal teams at digital platforms and online marketplaces approaching announceable transactions that engage the 2025 OECD Merger Review Recommendation are increasingly using AI to draft regulatory-strategy memos on remedies hierarchy, generate executive-committee briefings on cross-border merger-clearance exposure, and validate Section IV.3 remedies-priority language against the OECD text before remedy negotiations open with authorities.

The RLB Specialist Panel put a set of practitioner-grade questions on the 2025 OECD Merger Review Recommendation to two frontier AI models with web search active. Each question is prepared by the Panel based on the workflows that legal teams at digital platforms and marketplaces actually use AI for under the OECD's 2025 revision of the Recommendation of the Council on Merger Review (OECD/LEGAL/0333). The Panel then binds every AI response to verbatim regulator-issued source text held as primary substrate.

On the 2025 OECD Merger Review Recommendation, the AI subjects returned a single hallucinated answer for legal teams at digital platforms and marketplaces, in the form of Misattributed Cross-Jurisdictional Doctrine.

For legal teams at digital platforms and marketplaces advising on cross-border merger transactions touching the 2025 OECD Merger Review Recommendation, citation accuracy on the operative architecture, on Section IV.3 remedies hierarchy, and on Section III.11.b failing firm defence is load-bearing in every authority-facing submission, every board memo, and every transactional document. A counterparty or competition authority who identifies a structural inflation, a misattributed sub-hierarchy, or a closed-cumulative-test framing on first reading calls the entire piece of advice into question.

The structural-architecture failure is the most directly visible: a board memo or regulator-facing submission that lists 'international co-operation' or 'monitoring' as operative RECOMMENDS sections is wrong on first reading. The Section IV.3 EU sub-hierarchy import is the most insidious failure, reading as authoritative because the EU framework is real, but presenting EU practice as OECD content imports the wrong normative baseline into the firm's remedy strategy.

The published Specialist Panel findings carry the following citation identifiers:

• RLB-H-INT-OECD-OECD-MERGER-REVIEW-RECOMMENDATION-2025-Q002-Sonnet46 (Section IV.3 structural-remedy hierarchy misattributed to EU practice)